Sanofi Winthrop Industrie
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- France
- Registered address
- 1 RUE DE LA VIERGE, AMBARES ET LAGRAVE, 33560, France (FRA)
- Operations here
- analysislabelmanufacturepack
- FDA identifiers
- FEI 3002808208 · DUNS 763683216
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- VAIDrug Quality Assurance2023-11-22
- VAIDrug Quality Assurance2018-04-20
- VAIDrug Quality Assurance2013-12-06
- NAIDrug Quality Assurance2011-11-04
- VAIDrug Quality Assurance2009-01-23
Drugs this plant is listed as making
6 distinct drugs across 11 products name this site in their FDA label.
- clopidogrelSanofi-Aventis U.S. LLC
- DronedaroneSanofi-Aventis U.S. LLC
- eliglustatGenzyme Corporation
- irbesartanSanofi-Aventis U.S. LLC
- irbesartan and hydrochlorothiazideSanofi-Aventis U.S. LLC
- Sevelamer CarbonateGenzyme Corporation
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.